Germany’s IEP GmbH, one of the world’s leading providers of innovative bio-catalytic enzyme processes, has been sold to a European subsidiary of Cambrex Corporation(CBM), a NYSE listed company.
23.03.2010
Transaction announcement IEP
Future Capital, Heidelberg Capital and SET sell enzyme provider IEP GmbH to Cambrex Corporation